Drug-eluting Bead-Transcatheter Arterial Chemoembolization for Advanced Hepatocellular Carcinoma Refractory to Conventional Lipiodol-based Transcatheter Arterial Chemoembolization.
Saito KobayashiKazuto TajiriAiko MurayamaToshiki EntaniYuka FutsukaichiKohei NagataKosuke TakahashiIchiro YasudaPublished in: Journal of hepatocellular carcinoma (2020)
DEB-TACE could be a therapeutic option for advanced HCC patients with c-TACE refractory and decreased liver function.
Keyphrases